Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Which conference?
If I were management, I'd wait until the share price were much higher before any such buyout were even considered. As the recent Dirks article pointed out, this thunk is still way undervalued. Especially for a Phase III and because the longer the study goes, the higher the price will go.
Is the May 15 meeting the one for shareholders? Why do you think share price will be affected then?
We don't understand why it isn't already trading between $5-$6.
And yeah, the chart definitely looks primed to move!
So as the article points out, we have to wait until 2017 to see shares POSSIBLY at $4? What is so great about that? Why not put your money to work elsewhere until then?
From a purely technical standpoint, the gap has now been filled. he market makers and big trading houses are now on board and ready to push this thing higher. Up from here, IMO.
The interview with Dr. chain on the front page of BioMedReports will help people get it.
Our sources tell us that this company is set to have a big 2012. Lots of news and new product launches, etc. I actually like their agricultural product more than I even like their fire stuff. Lots of potential here.
Not surprised. Its actually a pretty clean and favorable financing. Last time these guys raised money, the stock went up nicely in the following days, so I wouldn't be surprised to see that again here.
If the stock gets past .45 it will test .70 next.
The good news here is that the chart lines up with what was reported far as buzz from the conference is concerned. The stock has been on a slow and quiet volume uptick the last few days. This makes sense and now the stock is past the 50 day moving average and it looks like it is headed higher.
Wow is right. Up from here.
Again... someone just trying to scare people out of shares with utter nonsense. Clueless.
The dead cat bounce will be in effect here amplified by the fact that this stock is pretty tightly held.
Biospecialist,
You're such a smart guy, answer me this. If this is a pump, which was alerted to subscribers at a lower price, then where is the dump? The stock is still trading higher than when Garza alerted it and is headed higher after FDA approval. I`m looking at all your previous picks and posts and it seems lime all you do is bash and/or jump on other people's ideas. Are you long this stock or just trying to scare people out of their shares? If Garza can bring volume like he did for this stock, then he obvisouly has juice. Wtf?
I agree Jukimol. This one is one to watch in 2012!
Not only that but insiders bought over three hundred thousand worth of shares last week. They're expecting this thing to go up!
Think we will see a reaction in the stock?
See the news alert posted at BiomMedReports.com about GTHP's FDA decision. Subscribers only section titled: "Chatter concerning upcoming FDA decision"
Article: Three microcap stocks set to move that smart money likes
http://www.marketwatch.com/story/set-to-move-three-micro-cap-stocks-that-analysts-and-instituional-investors-like-2011-12-06
News: Three Microcap Stocks Set To Move
http://www.marketwatch.com/story/set-to-move-three-micro-cap-stocks-that-analysts-and-instituional-investors-like-2011-12-06
Lists LPTN as a winner with a lot of institutional buys and strong buy recommendation with $8 price target!
Very good article on Seeking Alpha today about why this company may be acquired by Pfizer. Worth checking out.
There are rumors of one offer for $1.50 a share already. Instituional investors in the stock believe each drug in the pipeline is worth at least .70 each, so i'm not sure they would accept.
I think the biggest issue for the firm is that they haven't really been out talking everyone about their value proposition.
LPTN Buyout chatter. Stock starting to move.
Check them out. Current deal with Pfizer in Phase II studies.
People think the stock is too risky given the previous complete reaponse letter from the FDA. If they get the approval, shares will pop.
I thimk the Ceo could have been more upbeat in his interview with BioMedReports but his answers didn't seem to bring much confidence with them.
What odds are you guys giving the firm for FDA approval.
That funding was terribly executed. They could have gotten a much better deal based on where the stock was trading, yet it seems like tbe company was caught off guard by the sudden momentum in the stock and the deal had already been done.
The analysts who cover this stock appear to agree with you. This is a solid company which will likely be sold for a lot of money by Odidi one day.
Intellipharmaceutics Reaches Key Milestone As Bigger One Approaches
http://www.biomedreports.com/2011110182447/intellipharmaceutics-reaches-key-milestone-as-bigger-one-approaches.html
Celsion's break-out appears to have wings after all
Technical break out with forward looking news...
http://www.biomedreports.com/2011110182446/celsions-breakout-has-wings.html
IPCI reaches key milestone; analysts raise price targets
http://www.biomedreports.com/2011110182447/intellipharmaceutics-reaches-key-milestone-as-bigger-one-approaches.html
Very bullish on SVFC. Read the latest article here:
http://www.biomedreports.com/2011102081464/stromal-vascular-fraction-stem-cells-show-efficacy-in-treating-periodontal-disease-in-leading-peer-reviewed-journal.html
New very bullish report on YM BioSciences...
http://www.biomedreports.com/2011103182340/preliminary-phase-ii-nimotuzumab-results-unveiled-by-ym-biosciences.html
The guys who run this company are top notch guys with a great, clean background and the technology is amazing. Multiple billion dollar applications if it works and only fourty million shares outstanding. This isnt like some of those other penny stocks out there that have hundreds of millions of shares or even a billion shares. We dont smell a scam here and that is a very good thing.
Mindano,
Thanks for your insight on what is going on here. I think that you have a very good and likely explanation. I think from a techical standpoint thisthing is setting up for a move higher too.
I don't get why anyone would be selling at these levels with such big upside from here. Every analyst that covers these guys seems to really dig the technology, management team and potential.
All the other competitors who trade in this space with wound healing technologies have billion plus market caps. It seems to me that SNWV is bound to get acquired or start trading at a higher valuation soon.
Yeah what do you make of that? Is this market manipulation or just some crazy seller who refuses to stop dumping shares?
The markets have been horrible and this one is still holding its own. That is a very positive sign. More to come, it looks like.
New report on the news wires from BioMedReports indicates that positive developments are on the horizon. Bullish on TPIV.